ページ3 - 最高のてんかん医師 - トップ97名の医師

Brain and Nerve Surgery

Prof. Dr. Yasef began his medical education at Istanbul University in 1973 and graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1979. He started his specialization in neurology at the same university in 1980 and became a neurologist in 1985. During his specialty training, he spent 6 months at Hacettepe University in the Neurology Department in Ankara.

After becoming a neurologist, he completed 3.5 years of obligatory government service, spending the first 1.5 years at the Iskenderun Navy Hospital and the next 2 years at Diyarbakır Social Security Hospital. He returned to Istanbul University in 1989.

Prof. Dr. Yasef worked abroad in the United States from 1990 - 1991, focusing on dementia and behavioral neurology.

In 1994, he became an Associate Professor and continued working at Istanbul University until 1999. Between 1999 - 2002, he worked at Florence Nightingale Hospital, and then at Kozyatağı Acıbadem Hospital from 2004 to 2013.

Since 2013, he has been a valuable part of the team at Florence Nightingale Hospital.

Specialties

• Dementia
• Epilepsy
• Headaches

Work Experience

• Military Service at Iskenderun Navy Hospital, 1985 - 1986
• State Service at Diyarbakır S.S.K. Hospital, 1986 - 1989
• Florence Nightingale Hospital, 1999 - 2002
• Kozyatağı Acıbadem Hospital, 2004 - 2013
• Florence Nightingale Hospital (Since 2013)

EDUCATION

• Graduated in General Medicine at Universidad Autónoma de Nayarit in Mexico
•  
• Training in Forensic Medicine at Jalisco Institute of Forensic Sciences in Mexico
•  
• Training in Regenerative Geriatric Medicine at Nordic University
•  
• Master’s Degree in Regenerative Medicine at Universidad Catolica de Murcia in Madrid, Spain
•  
• Training in Regenerative Medicine at Nordic University

EXPERIENCE

• Founder of the biotechnological institute “Bioplenum S.A de C.V”
•  
• Collaborated in clinical protocols in Lyon, France, with Dr. Lourdes Sagnard
•  
• Clinical researcher in many protocols involving mesenchymal stem cells to treat autoimmune and chronic degenerative diseases, including: diabetes, asthma, ischemic events, ALS (Lou Gehrig’s disease), arthritis, kidney failure, lupus, aesthetic facial regeneration, and as an anti-inflammatory and immunomodulatory agent

ACCOLADES

• HemoFenix France representative in Mexico and Latin America
•  
• Kimicor Pharma representative at the Italian laboratory in Mexico
•  
• Krebs International, General Director for the company located in Bulgaria
•  
• General Director for Immunotherapy for México A.C. foundation

Specialist in Neurology
Head of the Advanced Neurosciences Unit – Quirónsalud

Professional Experience

Head of the Neurology Service
Hospital Universitario de Torrevieja (2018 – 2021)
Led a multidisciplinary neurology team with a focus on patient-centered care, especially for neurodegenerative disorders.

Head of Neurology Service
Hospital Clínica Benidorm (2017 – 2018)
Oversaw diagnostic and therapeutic services in general neurology, epilepsy, and movement disorders.

Consultant Neurologist
Hospital General Universitario de Alicante (2017 – 2018)
Specialized in inpatient and outpatient neurology services, actively participated in teaching and research.

Consultant Neurologist
Hospital de Manises, Valencia (2016 – 2017)
Focus on epilepsy and complex neurological diagnostics.

General Practitioner
Baghavatula Charitable Trust (BCT), Vishakapatnam, India (2012 – 2016)
Provided healthcare services in underserved rural communities, gaining valuable experience in global medicine.

Education & Training

Medical Degree
Universidad Autónoma de Madrid (UAM) (2005 – 2011)

Neurology Residency (MIR Program)
Hospital General Universitario de Alicante (2012 – 2016)

Postgraduate Studies

Postgraduate Specialization in Movement Disorders
Universidad Oberta de Catalunya (2019 – 2020)

Postgraduate Specialization in Clinical Research
Chair UAM-Abbvie (2020 – ongoing)

Master in Healthcare Management
UDIMA - Universidad a Distancia de Madrid (2020 – ongoing)

Master in Clinical Neurology
Universidad Francisco de Vitoria (2020 – ongoing)

Professional Societies

Member of the Valencian Society of Neurology (SVN)

Member of the Spanish Society of Neurology (SEN)

Scientific Contributions

Publications:

"Creutzfeldt-Jakob Disease – Heidenhain Variant" – Presented at the 66th Meeting of the Spanish Society of Neurology (2015)

"Sleepwalking or Epilepsy?" – Presented at the 39th Annual Meeting of the Spanish Society of Neuropediatrics (2016)

Conferences & Courses:

Epilepsy Hospital Stage Course – Hospital La Princesa, Madrid (2020)

Updates on Parkinson’s Disease and Movement Disorders – Movement Disorder Society, 2019

American Epilepsy Society Annual Meeting – Baltimore, USA (2019)

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

Education & Expertise

1996 to 2000 | Dicle University – Medical Education

Professional Experience

2001 to 2006 | Diyarbakır State Hospital – Neurology Specialist

2006 to 2009 | Düzce Atatürk State Hospital – Neurology Specialist

2009 to 2013 | Düzce University – Associate Professor of Neurology

2013 to 2016 | Düzce University – Associate Professor of Neurology

2017 to 2024 | Pendik Private Century Hospital – Associate Professor of Neurology

2024 to Present | VM Medical Park Pendik Hospital – Associate Professor of Neurology

Courses & Certifications

June, 2012 | Trainer Training Course

February, 2010 | Trainer Training Course

March, 2011 | Sleep Medicine Certification Program Preparation Course

December, 2012 | Sleep Disorders Diagnosis and Treatment Course

DBS Application Training and Course – Dubai

Professional Memberships

Turkish Medical Association

Turkish Neurology Association

Turkish Sleep Medicine Association

Awards & Recognitions

2014 | Düzce University Rectorship – Publication Success Incentive Award

Dr. Fatma Gulhan Sahbaz is a neurologist. She graduated from Manisa Celal Bayar University Faculty of Medicine. She completed her neurology residency at SBÜ Istanbul Kartal Dr. Lütfi Kırdar Training and Research Hospital. Dr. Sahbaz has served as Clinic Chief at Afyonkarahisar State Hospital. She currently practices at İzmir Ekonomi University Medical Point Hospital.

She treats many neurological conditions, including Alzheimer’s disease, ALS, epilepsy, cerebrovascular diseases, brain tumors, movement disorders, and headaches. Dr. Sahbaz is experienced in advanced treatments such as acute stroke intervention, deep brain stimulation, IVIG therapy, and botulinum toxin injections.

She is a member of the Turkish Neurology Society, International Parkinson and Movement Disorder Society, and European Academy of Neurology.

Education and Expertise

• 1999 – 2005 – FIRAT UNIVERSITY FACULTY OF MEDICINE
• 1995 – 1999 – IZMIR ATATURK HIGH SCHOOL

Diseases

• Alzheimer’s type dementia
• Headaches
• Dizziness
• Cerebrovascular diseases
• Vascular diseases
• Dementia Diseases
• Demyelinating Diseases
• Epilepsy
• Movement Disorders
• Migraine
• Myopathies
• MOGAD

Treatment Methods

• Botox
• Duodopa Treatment
• Intravenous Thrombolytic
• IVIG Treatment
• Migraine vaccine
• Migraine Botox

Experience

• 2005-2010 – Ege University Faculty of Medicine, Department of Neurology, Specialization Student, Izmir.
• 2010-2012 – İzmir Tire State Hospital Neurology Department
• September 2012 – May 2013 – Çanakkale 18 March University, Faculty of Medicine, Department of Neurology, Assistant Professor.
• 2013 – Medical Point Izmir Hospital Neurology Department

Professional Memberships

• Turkish Neurology Association

Education

2005 – 2011 | Kocaeli University, Faculty of Medicine, Kocaeli, Turkey
M.D. Degree

2013 – 2019 | Erenköy Mental Health and Neurology Training and Research Hospital, Istanbul, Turkey
Neurology Residency Program

Languages

English – Very Advanced

Professional Experience

Artvin Borçka State Hospital, Artvin, Turkey
General Practitioner (Compulsory Service)
2011 – 2012

Erenköy Mental Health and Neurology Training and Research Hospital, Neurology Department, Istanbul, Turkey
Resident Physician
2013 – 2019

Siirt State Hospital, Siirt, Turkey
Neurology Specialist (Compulsory Service)
2019 – March 2021

Private Pendik Medical Park Hospital, Istanbul, Turkey
Neurology Specialist
April 3, 2021 – April 10, 2024

Bahçeşehir University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Assistant Professor
April 19, 2021 – June 1, 2024

Medipol Acıbadem Regional Hospital, Istanbul, Turkey
Associate Professor of Neurology
April 22, 2024 – Present

Istanbul Medipol University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Associate Professor of Neurology
November 11, 2024 – Present

Memberships

Turkish Neurology Society

Turkish Medical Association

International Parkinson and Movement Disorder Society

Turkish Neurology Society Neurorehabilitation Working Group

Global Migraine and Pain Society

International Headache Society

Turkish Parkinson’s Disease Society

Turkish Alzheimer Association, Kadıköy Branch

Areas of Interest

Parkinson’s disease and other movement disorders

Migraine and other headache disorders

Sleep disorders

Dementia and Alzheimer’s disease

EEG, Polysomnography (PSG), Multiple Sleep Latency Test (MSLT)

Botulinum toxin injections for movement disorders

Nerve blocks and botulinum toxin for headache management

Epilepsy

Assoc. Prof.  Nesrin Helvacı Yılmaz graduated from Hacettepe University in 2000 as a Medical Doctor.  She completed her specialty training in the Department of Neurology at Ankara University in 2006.

She started her compulsory service in Mardin Nusaybin State Hospital in 2007.  Nesrin Helvacı Yılmaz continued her duty in Gaziantep 27 December State Hospital in 2008.  She worked as a neurologist at Biophysis Nilüfer Medical Center and Ali Osman Sönmez Oncology Hospital in Bursa between 2010-2011, and at Istanbul Universal Aksaray Hospital between 2011-2012. From October 2012, she started to work as a Doctor Lecturer in Istanbul Medipol University Neurology Department.  Nesrin Helvacı Yılmaz received the title of associate professor in 2021.  In 2015, she worked as an Honorary Observer in Parkinson's Disease and Deep Brain Stimulation (Neuromodulation) at UCL Queen Square Institute of Neurology, National Hospital for Neurology in London.  She took part in many training programs on Deep Brain Stimulation (Neuromodulation) in Turkey and abroad between 2013-2022.

Regarding her speciality in Parkinson's disease and movement disorders, she has 5 Tubitak projects, a 2-chapter book , 30 clinical researches and 80 reports presented in domestic and abroad. Assoc. Prof. Nesrin Helvacı Yılmaz, who is still working within the staff of Medipol University, managed the Parkinson's and Movement Disorders Unit of the Department of Neurology during her working time and plans Deep Brain Stimulation therapy applications with the neurosurgical team.

Since September 2018, she has been working as a coordinator for student education in the 5th semester of Neurology. As of December 2022, she has developed treatment plans for patients at Medipol University Istanbul Parkinson's Disease and Movement Disorders Center (PARMER) and provides the most appropriate personal medical follow-up and treatment support for each patient.

PUBLICATIONS

1-Yilmaz N, Yigit A, Akbostanci MC. Clozapine induced epilepsy. Revue Neurologique 2004, Nov;160/11:1093.

2-Nesrin Helvacı Yılmaz, Nursel Aydın. Sıcak Su Epilepsili Bir Olgu. Türkiye Klinikleri Nöroloji Dergisi 2004/Cilt2/Sayı 2.

3-Nesrin Helvacı Yılmaz, Nursel Aydın. Refleks Epilepsiler. Türkiye Klinikleri Nöroloji Dergisi 2004/Cilt2/Sayı 2.

4-Mine Hayriye Sorgun, Bilge Koçer, Funda Kaplan, Nesrin Yılmaz, Nezih Yücemen, Canan Yücesan. Multipl Sklerozda Kraniyal Nöropati. Turk Norol Derg 2011;17:137-142.

5-Nesrin Helvacı Yılmaz, Gökçen Duymaz, Mehmet Akif Yaşar. Parkinson Hastalığı Olan Bir Olguda Malign Sendrom. Turk Norol Derg 2012:18;123-125.

6-Yilmaz NH, Akbostanci MC, Oto A, Aykac O. Prevalence of restless legs syndrome in Ankara, Turkey: an analysis of diagnostic criteria and awareness. Acta Neurol Belg 2012 Oct 31. [Epub ahead of print].

7-Yılmaz NH, Bingol AP. Sensitivity and specificity of Ankara University Cerebral Dominance Inventory in comparison with the Wada test. Acta Neurol Belg 2013 Jun 6 [Epub ahead of print].

8-Sema Demirci, Nesrin Helvacı Yılmaz, Efsun Şenocak, Fatih Han Bölükbaşı. Pons Kavernomu: Kranial Manyetik Rezonans Görüntüleme Bulguları. Turk Norol Derg 2012:19:72.

9-Nesrin Helvacı Yılmaz, Sinem Atik Güngör, Taflan Sahlepçi. Küçük hücreli akciğer kanseri tedavisinde cisplatin kullanımı sırasında gelişen akut iskemik inme: olgu sunumu. J Kartal TR. Baskıdaki Makaleler: KEAH-26937.

POSTERLER:

-Serebral venöz tromboz ve bruselloz Birlikteliği; Olgu Sunumu (42. Ulusal Nöroloji Kongresi-Antalya 2006)

-Waldenström makroglobulinemisine eşlik eden epileptik nöbetler ve nonkonvülsif status epileptikus (42. Ulusal Nöroloji Kongresi-Antalya 2006)

-Prevalence of Restless Legs Syndrome in Ankara, Turkey (16. Uluslararası Parkinson ve Hareket Bozuklukları Kongresi-Dublin 2012).

-Konjenital Miyastenik Sendrom (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-Beşinci haftada duyusal iletimleri normal olan bir enjeksiyon nöropatisi olgusu (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-Olgu sunumu: Mononöritis mültipleks ve lepra (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-İdyopatik Parkinson Hastalığı’nda hızlanmış unutma ve uyku kalitesi (10. Ulusal Parkinson ve Hareket Bozuklukları Kongresi-Antalya 2013).

-Hiperglisemiye bağlı hemikore ve bazal gangliyon hiperintensitesi: Olgu sunumu (10. Ulusal Parkinson ve Hareket Bozuklukları Kongresi-Antalya 2013).

ウタ・マイディング＝ラマデ教授は、ドイツにおける主要な神経科医の一人であり、インスルト、多発性硬化症、リウマチ性疾患および神経障害の治療に特化しています。

ドクターは1988年にハイデルベルク大学を卒業し、その後、ユニバーシティ・カレッジ・ロンドンとメンフィス大学でポストグラデュエートトレーニングを受けました。

現在、マイディング＝ラマデ教授は：

• ノルトヴェスト・クリニックの神経科部門を率いる
• ウイルス性脳炎のドイツ神経学会を率いる（Deutsche Gesellschaft für Neurologie）。
• ロバート・コッホ研究所でインスルト治療に関する地域アドバイザーをしている。

ドクターは多くの奨学金や賞を受けており、革新的な肺炎治療法に対してブラウン財団賞を含みます。

EDUCATION:

2014 ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE, CHILD HEALTH AND DISEASES, CHILD NEUROLOGY

2011 IZMIR EDUCATION AND RESEARCH HOSPITAL, CHILD HEALTH AND DISEASES

2011 Izmir Tepecik Education and Research Hospital, Child Health and Diseases

2004 DICLE UNIVERSITY, FACULTY OF MEDICINE

EXPERIENCE:

2018 Istanbul Medipol Hospital

2017 - 2018 Kartal Education and Research Hospital

2014 - 2016 Denizli State Hospital

2011 - 2014 Aydin Adnan Menderes University Faculty of Medicine Hospital

2006 - 2011 Izmir Tepecik Education and Research Hospital

2011Izmir Education and Research Hospital

Neurologist. Head of the Center for Epilepsy

Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.

Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.

She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.

Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.

Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.

He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).

• Staff physician, Epilepsy Group, Department of Child Neurology, Hospital Sant Joan de Déu.
• Clinical Research Assistant, Department of Epilepsy, Sleep and Neurofunctional Research in Children.

Somjet Tosamran, MD, is a neurologist. Dr. Tosamran is a fellow in epilepsy at the Neurology Division, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (2024–present). Dr. Tosamran completed a neurology residency at the same hospital (2021–2024). Earlier training includes internships at Charoenkrung Pracharak Hospital and Sakaeo Crown Prince Hospital.

Accreditations and education: Neurologist certification, King Chulalongkorn Memorial Hospital (2024). Master of Science in Internal Medicine, Faculty of Medicine, Chulalongkorn University (2024). Doctor of Medicine, First Class Honors, Faculty of Medicine, Chulalongkorn University (2018).

アレクシス・アズミノグル博士は、30年の経験を持つ小児てんかん専門医です。彼は、児童てんかんの医学的および外科的治療、認知発達障害（知覚、記憶、論理などのあらゆる種類の思考過程）、および病気の局所形態における感情の調整を専門としています。

現在、アズミノグル博士はバルセロナのサンジョアン・デ・デウ小児病院でてんかんプログラムを調整し、リヨン大学病院（フランス）のてんかん、睡眠障害および小児神経生理学ユニットを率いています。

アレクシス・アズミノグルは、てんかんの薬物および外科的治療、小児てんかんの遺伝的特徴、および局所てんかんに関連する脳の障害の分野で臨床研究に関与しています。

科学活動

• 自閉症および神経発達障害専門委員会の会長;
• 国際てんかん対策リーグ（ILAE）からのてんかん大使賞の受賞者;
• フランス、リヨン大学病院での「てんかんおよび気分障害: 新たに診断された子供における前向き縦断研究」研究の主研究者およびコーディネーター;
• 「小児神経学」専門のヨーロッパ神経学アカデミーの科学グループの共同議長;
• 小児てんかんに関する124の科学論文と10冊の本の著者。

Neurologist